July 27, 2020
Canon Medical and FC Barcelona have today announced a renewal of their partnership deal, which will see the medical device company supplying the club with leading-edge diagnostic imaging systems for a further five seasons.
July 27, 2020
Canon Medical and Real Madrid have today announced that the Japanese medical device company will remain the club’s official diagnostic imaging partner for a further five seasons.
July 15, 2020
Canon Medical Systems Corporation and Fujita Health University are starting clinical evaluation of the usefulness of new technology to improve the diagnosis of novel coronavirus pneumonia based on CT image analysis focusing on diffuse pulmonary diseases.
June 22, 2020
Canon Medical Systems Corporation has agreed on establishing a joint venture with leading Russian healthcare provider, R-Pharm Holding, LLC, for sales and maintenance of diagnostic imaging equipment manufactured by Canon Medical in nine CIS member states, including Russia, and will consummate the joint venture when all the necessary regulatory approvals are obtained.
May 7, 2020
TOKYO, May 7,2020—As part of Canon Inc.’s global medical business strategic realignment, in order to take advantage of medical imaging company expertise and business synergies, the eye care business operations within Canon (China) Co., Ltd. has been transferred to Canon Medical Systems (China) Co., Ltd. (hereinafter referred to as Canon Medical China) effective May 1, 2020.
March 26, 2020
Canon Medical Systems Corporation, working together with Nagasaki University, has completed development of Genelyzer KIT, a set of reagents for SARS-CoV-2 RNA testing based on a gene amplification technique known as the fluorescent LAMP method.
March 19, 2020
Canon Medical Systems Corporation has begun research into the practical application of a new rapid genetic testing system for the novel coronavirus (SARS-CoV-2) which is being developed by Canon Medical Systems Corporation in cooperation with Nagasaki University.
February 25, 2020
Ohtawara, Japan; February 26 Canon Medical Systems Corporation (Canon Medical) announces the start of development of a rapid genetic testing system for the novel coronavirus (COVID-19) reaffirming the company’s commitment to the basic research and development of rapid diagnostic test kits.
January 30, 2020
Canon (China) Co., Ltd., Canon Medical Systems (China) Co., Ltd. and all members of the Canon Group, via the National Health Commission of the People’s Republic of China, will donate a full-body X-ray CT diagnosis system to the Tongji Hospital of Tongji Medical College, Huazhong University of Science and Technology, in the city of Wuhan.
December 10, 2019
As part of Canon Inc.’s global medical business strategic realignment, the eye care business operations within Canon U.S.A., Inc. will transfer to Canon Medical Systems USA, Inc. effective January 1, 2020.
December 3, 2019
As part of Canon Inc.’s global medical business strategic realignment, the X-ray business operations within U.S.A., Inc.’s wholly owned subsidiary Virtual Imaging, Inc. will transfer to Canon Medical Systems USA, Inc. (CMSU) effective January 1, 2020.
November 25, 2019
Canon Medical Systems Corporation has concluded a contract to acquire all shares of Skope Magnetic Resonance Technologies AG.
October 14, 2019
Canon Medical Systems Corporation is pleased to announce the official opening of its Middle East Division in Canon Middle East Dubai, UAE. Preparations are now underway to start business operations around the beginning of January 2020.
September 10, 2019
Canon Medical Systems Corporation (Canon Medical) announces completion of an agreement with US-based FemtoDx, Inc. (FemtoDx) relating to a capital investment based on stock purchase.
August 1, 2019
Canon Inc. (Headquarters: Ohta-ku, Tokyo, Japan; Chairman and CEO: Fujio Mitarai) Canon Medical Systems Corporation (“Canon Medical”; Headquarters: Tochigi Prefecture, Japan; President: Toshio Takiguchi) and the Center for iPS Cell Research and Application, Kyoto University (“CiRA”; Headquarters: Sakyo-ku, Kyoto, Japan; Director: Shinya Yamanaka) announced today that the parties have agreed to commence joint research from August 1, 2019, with the aim of contributing to the field of regenerative medicine through the realization of higher-quality induced pluripotent stem (iPS) cells1 for autograft purposes, or “my iPS cells2.”
July 1, 2019
Canon Medical Systems Corporation (Headquarters: Otawara, Tochigi Prefecture, Japan; President and CEO: Toshio Takiguchi) has agreed to establish a framework with R-Pharm Holding (a part of R-Pharm Group, headquarters: Moscow, Russia; Chairman and President: Alexey Repik), a leader of Russian healthcare market, to promote sales of diagnostic imaging systems manufactured by Canon Medical Systems, and to localize Canon’s medical equipment production at R-Pharm’s facilities in Russia.
May 16, 2019
Otawara, Japan; May 16, 2019- Canon Medical Systems Corporation (Canon Medical) will present Deep Learning Reconstruction (DLR) technology at the International Society for Magnetic Resonance in Medicine (ISMRM) 2019 Annual meeting in Montreal, Vancouver.
January 30, 2019
January 28, 2019; Otawara, Japan – Canon Medical Systems Corporation (Canon Medical) introduces Global Illumination rendering technology within the Vitrea® platform. This technology allows physicians to interact in real-time with photorealistic images and visualize patient anatomy in all dimensions.
January 28, 2019
Canon Medical Systems Corporation (Canon Medical) to launch new Aquilion Start CT system at Arab Health in Dubai, United Arab Emirates from 28 -31 January, 2019.
November 20, 2018
Canon Medical Systems Corporation and Ichiban S.A. de Inversión reached an agreement on the conditions for transferring the assets related to the distributor business of GRIENSU S.A. to Canon Medical Systems Argentina S.A. on August 7, 2018 (local time).
© CANON MEDICAL SYSTEMS CORPORATION
© CANON MEDICAL SYSTEMS CORPORATION